Jeffrey Allen Morris - 27 Mar 2023 Form 3 Insider Report for PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT)

Role: 10%+ Owner
Signature: /s/ Jeffrey Allen Morris
Issuer symbol: PVCT
Transactions as of: 27 Mar 2023
Net transactions value: $0
Form type: 3
Filing time: 28 Mar 2023, 09:10:15 UTC
Next filing: 09 May 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	PVCT	Common Stock						18,500,000	27 Mar 2023	Direct	F1
holding	PVCT	Series D-1 Convertible Preferred Stock						3,806,990	27 Mar 2023	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	PVCT	8% Secured Convertible Promissory Note							27 Mar 2023	Series D-1 Convertible Preferred Stock	$500,000	$2.86	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reporting person has sole voting and dispositve power over 12,000,000 shares of Common Stock, plus 6,500,000 shares of Common Stock owned through a retirement plan.
F2	The reporting person has sole voting and dispositve power over 3,806,990 shares of Series D-1 Convertible Preferred Stock, convertible into 38,069,900 shares of Common Stock.
F3	The outstanding principal and interest of the Note will automatically convert into shares of Series D-1 Convertible Preferred Stock at a price of $2.862 per share on 05/05/2023.